SlideShare a Scribd company logo
.
J Mereckiene 1,9, S Cotter 1,9, K Johansen2, S Tsolova2, P Penttinen2, F D'Ancona3,9, D Levy-Bruhl 4,9, O Wichman7,9, L Demattè5,9, P Valentiner-Branth6,9, I Stankiewicz7,9, D O’Flanagan 1,9 on behalf of the VENICE project gatekeepers group10
Introduction
The European Council recommendation on seasonal
influenza vaccination adopted in 2009 encourages EU/EEA
Member States (MSs) to improve vaccination coverage
among healthcare workers (HCWs). Similarly, the WHO
SAGE in their recommendation from 2012 states that
HCWs are an important priority group.
In the context of these recommendations we assessed
reported policy, available payment schemes and
measured/estimated uptake of seasonal influenza vaccines
in health care workers in EU/EEA countries.
Methods
A standardized online survey questionnaire was developed
by the Vaccine European New Integrated Collaboration
Effort (VENICE III) network and made available in
December 2015 to all EU/EEA MS gatekeepers (n=31).
Descriptive analysis of data on vaccine policy and payment
schemes provided by each responding EU/EEA MS was
carried out. Vaccination coverage rates (VCR) were
calculated as proportions of the number of vaccinated
individuals (numerator) divided by the total number of
individuals in the population groups targeted for vaccination
(denominator) in each MS. VCR information was collected
either by the administrative method or the survey method.
Results
• Of 30 responding countries, 29 recommended seasonal
influenza vaccine to HCWs ahead of the 2014/2015
influenza season. In Denmark, no national
recommendation was available, but most regions and
municipalities offer vaccination free of charge.
• Vaccination was recommended to all HCWs in 24
EU/EEA MS, while another 4 recommend vaccination to
staff in close patient contact or staff caring for
immunocompromised patients only. In the UK,
vaccination was recommended for all HCWs in Northern
Ireland and Scotland, while England and Wales
recommended vaccination of front line HCWs only or
those HCWs who have direct contact with patients.
Policy recommendations, payment schemes and uptake of seasonal influenza vaccine in health care
workers in EU/EEA Member States assessed for the 2009/2010 to 2014/2015 influenza seasons
• No MS enforces mandatory vaccination of staff. Some
health care settings in MSs required unvaccinated staff
to wear a mask during the influenza season.
• Payment schemes for vaccine/vaccination varied, with
the employer, national or regional health services
covering the cost of in 19 MS while 4 reported that at
least some HCWs paid out of pocket. In the remaining
seven countries a combination of several payment
mechanisms exists (e.g. private insurance, out of pocket,
employer or national insurance scheme).
• Uptake of seasonal influenza vaccination in HCWs was
reported from fourteen EU/EEA MS and ranged between
5-55% in 2014-15. Information was collected by the
administrative method (n= 13) or the survey method
(n=1). Uptake in HCWs was often but not always lower
than uptake in older populations, with a median uptake
of ~25% among HCWs (n=17) compared to ~40% in
older populations (n=26).
Figure 2. Seasonal influenza vaccination coverage rates among HCWs in
EU/EEA MSs 2009-10 to 2014-15 influenza seasons
No recommendation
Recommended for all HCWs
Recommended for some* HCWs
* Health care workers in GPs practice/Outpatient health care settings
Conclusions
• Vaccine policy recommendations for HCWs to be
vaccinated against influenza exist in almost all
EU/EEA MSs
• Payment schemes vary but are available in all
EU/EEA MSs.
• Among those EU/EEA MSs reporting uptake there
is room for significant improvement in uptake of
seasonal influenza vaccination in HCWs
• There is a need for collection of uptake of seasonal
influenza vaccination in HCWs in all EU/EEA MSs
Affiliations: 1Health Protection Surveillance Centre, Dublin, Ireland , 2European Centre for Disease Prevention and Control, Stockholm, Sweden, 3Istituto Superiore di Sanità, Rome, Italy, 4Institut de Viellle Sanitaire, Saint-Maurice, France,5CINECA Consortium of Universities, Bologna, Italy, 6Statens Serum Institut, Copenhagen, Denmark,
7Robert Koch Institute, Berlin, Germany, 8National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland, 9Vaccine European New Integrated Collaboration Effort (VENICE) Project, 10The list of gatekeepers is available in the final report on VENICE website: http://venice.cineca.org
Acknowledgements: We are grateful to all VENICE gatekeepers/contact points in each EU/EEA MS that contributed data presented on this poster,
Figure 1. EU/EEA MSs recommending seasonal influenza vaccine for
health care workers.
*Some is defined as e.g. outpatient/inpatient/long term care facilities workers/ front line HCWs/ those
HCWs who have direct contact with patient.
0
10
20
30
40
50
60
70
80
90
100
Vaccinationcoverage(%)
2009-10 2010-11 2011-12 2012-13 2013-14 2014-15

More Related Content

Viewers also liked

Avian influenza in the Netherlands
Avian influenza in the NetherlandsAvian influenza in the Netherlands
Avian influenza in the Netherlands
Cornelia Adlhoch
 
HEV surveillance in EU/EEA, 2015
HEV surveillance in EU/EEA, 2015HEV surveillance in EU/EEA, 2015
HEV surveillance in EU/EEA, 2015
Cornelia Adlhoch
 
basic information about avian influenza viruses
basic information about avian influenza virusesbasic information about avian influenza viruses
basic information about avian influenza viruses
Geranne Kiezebrink
 
Les 1 neurowetenschappen
Les 1 neurowetenschappenLes 1 neurowetenschappen
Les 1 neurowetenschappen
greetdierckx
 
Speaking Millennial Through Your Retirement Plan
Speaking Millennial Through Your Retirement PlanSpeaking Millennial Through Your Retirement Plan
Speaking Millennial Through Your Retirement Plan
Stephanie Hogan
 
Observado
ObservadoObservado
Observado
JUAN BUSTAMANTE
 
Presentacion elmer hidalgoo
Presentacion elmer hidalgooPresentacion elmer hidalgoo
Presentacion elmer hidalgoo
Elmer Hidalgo Acuña
 
เสนอ2
เสนอ2เสนอ2
เสนอ2
natakorn011
 
The Ultimate Guide to Social Media Image Sizes
The Ultimate Guide to Social Media Image SizesThe Ultimate Guide to Social Media Image Sizes
The Ultimate Guide to Social Media Image Sizes
Custom Creatives
 
Polling system solution using blockchain & Liferay
Polling system solution using blockchain & LiferayPolling system solution using blockchain & Liferay
Polling system solution using blockchain & Liferay
Dhanraj Dadhich
 
H1N1 Vaccination, should you get it?
H1N1 Vaccination, should you get it?H1N1 Vaccination, should you get it?
H1N1 Vaccination, should you get it?
Kenneth Tran
 
The Demographic Effect BEFORE
The Demographic Effect BEFOREThe Demographic Effect BEFORE
The Demographic Effect BEFORE
Stephanie Hogan
 
SNAPSHOT ON INFLUENZA VACCINE ,Dr. Sharda Jain Dr. Jyoti Agarwal Dr. Jyoti ...
SNAPSHOT ON INFLUENZA VACCINE ,Dr. Sharda Jain  Dr. Jyoti Agarwal  Dr. Jyoti ...SNAPSHOT ON INFLUENZA VACCINE ,Dr. Sharda Jain  Dr. Jyoti Agarwal  Dr. Jyoti ...
SNAPSHOT ON INFLUENZA VACCINE ,Dr. Sharda Jain Dr. Jyoti Agarwal Dr. Jyoti ...
Lifecare Centre
 

Viewers also liked (13)

Avian influenza in the Netherlands
Avian influenza in the NetherlandsAvian influenza in the Netherlands
Avian influenza in the Netherlands
 
HEV surveillance in EU/EEA, 2015
HEV surveillance in EU/EEA, 2015HEV surveillance in EU/EEA, 2015
HEV surveillance in EU/EEA, 2015
 
basic information about avian influenza viruses
basic information about avian influenza virusesbasic information about avian influenza viruses
basic information about avian influenza viruses
 
Les 1 neurowetenschappen
Les 1 neurowetenschappenLes 1 neurowetenschappen
Les 1 neurowetenschappen
 
Speaking Millennial Through Your Retirement Plan
Speaking Millennial Through Your Retirement PlanSpeaking Millennial Through Your Retirement Plan
Speaking Millennial Through Your Retirement Plan
 
Observado
ObservadoObservado
Observado
 
Presentacion elmer hidalgoo
Presentacion elmer hidalgooPresentacion elmer hidalgoo
Presentacion elmer hidalgoo
 
เสนอ2
เสนอ2เสนอ2
เสนอ2
 
The Ultimate Guide to Social Media Image Sizes
The Ultimate Guide to Social Media Image SizesThe Ultimate Guide to Social Media Image Sizes
The Ultimate Guide to Social Media Image Sizes
 
Polling system solution using blockchain & Liferay
Polling system solution using blockchain & LiferayPolling system solution using blockchain & Liferay
Polling system solution using blockchain & Liferay
 
H1N1 Vaccination, should you get it?
H1N1 Vaccination, should you get it?H1N1 Vaccination, should you get it?
H1N1 Vaccination, should you get it?
 
The Demographic Effect BEFORE
The Demographic Effect BEFOREThe Demographic Effect BEFORE
The Demographic Effect BEFORE
 
SNAPSHOT ON INFLUENZA VACCINE ,Dr. Sharda Jain Dr. Jyoti Agarwal Dr. Jyoti ...
SNAPSHOT ON INFLUENZA VACCINE ,Dr. Sharda Jain  Dr. Jyoti Agarwal  Dr. Jyoti ...SNAPSHOT ON INFLUENZA VACCINE ,Dr. Sharda Jain  Dr. Jyoti Agarwal  Dr. Jyoti ...
SNAPSHOT ON INFLUENZA VACCINE ,Dr. Sharda Jain Dr. Jyoti Agarwal Dr. Jyoti ...
 

More from European Centre for Disease Prevention and Control

Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018
European Centre for Disease Prevention and Control
 
HIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 dataHIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 data
European Centre for Disease Prevention and Control
 
Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)
European Centre for Disease Prevention and Control
 
90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action
European Centre for Disease Prevention and Control
 
The public health response to increasing syphilis trends in Europe
The public health response to increasing  syphilis trends in EuropeThe public health response to increasing  syphilis trends in Europe
The public health response to increasing syphilis trends in Europe
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
European Centre for Disease Prevention and Control
 
Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States
European Centre for Disease Prevention and Control
 
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted DiseasesAnnual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
European Centre for Disease Prevention and Control
 
The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...
European Centre for Disease Prevention and Control
 
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 dataSurveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
European Centre for Disease Prevention and Control
 
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak InvestigationWhole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
European Centre for Disease Prevention and Control
 
Respondent Driven Sampling
Respondent Driven Sampling Respondent Driven Sampling
Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)
European Centre for Disease Prevention and Control
 
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
European Centre for Disease Prevention and Control
 
HIV/AIDS surveillance in Europe 2018 (2017 data)
HIV/AIDS surveillance in Europe  2018 (2017 data)HIV/AIDS surveillance in Europe  2018 (2017 data)
HIV/AIDS surveillance in Europe 2018 (2017 data)
European Centre for Disease Prevention and Control
 
Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?
European Centre for Disease Prevention and Control
 
Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
European Centre for Disease Prevention and Control
 
Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016 Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 dataTuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
European Centre for Disease Prevention and Control
 

More from European Centre for Disease Prevention and Control (20)

Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019
 
Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018
 
HIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 dataHIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 data
 
Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)
 
90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action
 
The public health response to increasing syphilis trends in Europe
The public health response to increasing  syphilis trends in EuropeThe public health response to increasing  syphilis trends in Europe
The public health response to increasing syphilis trends in Europe
 
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
 
Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States
 
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted DiseasesAnnual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
 
The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...
 
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 dataSurveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
 
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak InvestigationWhole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
 
Respondent Driven Sampling
Respondent Driven Sampling Respondent Driven Sampling
Respondent Driven Sampling
 
Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)
 
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
 
HIV/AIDS surveillance in Europe 2018 (2017 data)
HIV/AIDS surveillance in Europe  2018 (2017 data)HIV/AIDS surveillance in Europe  2018 (2017 data)
HIV/AIDS surveillance in Europe 2018 (2017 data)
 
Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?
 
Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
 
Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016 Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016
 
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 dataTuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
 

Recently uploaded

CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
DIVYANSHU740006
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Hiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital Powai News [Read Now].pdfHiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital Powai News [Read Now].pdf
Dr. Sujit Chatterjee CEO Hiranandani Hospital
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
Gokuldas Hospital
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 

Recently uploaded (20)

CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Hiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital Powai News [Read Now].pdfHiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital Powai News [Read Now].pdf
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 

Policy recommendations, payment schemes and uptake of seasonal influenza vaccine in health care workers in EU/EEA Member States assessed for the 2009/2010 to 2014/2015 influenza seasons

  • 1. . J Mereckiene 1,9, S Cotter 1,9, K Johansen2, S Tsolova2, P Penttinen2, F D'Ancona3,9, D Levy-Bruhl 4,9, O Wichman7,9, L Demattè5,9, P Valentiner-Branth6,9, I Stankiewicz7,9, D O’Flanagan 1,9 on behalf of the VENICE project gatekeepers group10 Introduction The European Council recommendation on seasonal influenza vaccination adopted in 2009 encourages EU/EEA Member States (MSs) to improve vaccination coverage among healthcare workers (HCWs). Similarly, the WHO SAGE in their recommendation from 2012 states that HCWs are an important priority group. In the context of these recommendations we assessed reported policy, available payment schemes and measured/estimated uptake of seasonal influenza vaccines in health care workers in EU/EEA countries. Methods A standardized online survey questionnaire was developed by the Vaccine European New Integrated Collaboration Effort (VENICE III) network and made available in December 2015 to all EU/EEA MS gatekeepers (n=31). Descriptive analysis of data on vaccine policy and payment schemes provided by each responding EU/EEA MS was carried out. Vaccination coverage rates (VCR) were calculated as proportions of the number of vaccinated individuals (numerator) divided by the total number of individuals in the population groups targeted for vaccination (denominator) in each MS. VCR information was collected either by the administrative method or the survey method. Results • Of 30 responding countries, 29 recommended seasonal influenza vaccine to HCWs ahead of the 2014/2015 influenza season. In Denmark, no national recommendation was available, but most regions and municipalities offer vaccination free of charge. • Vaccination was recommended to all HCWs in 24 EU/EEA MS, while another 4 recommend vaccination to staff in close patient contact or staff caring for immunocompromised patients only. In the UK, vaccination was recommended for all HCWs in Northern Ireland and Scotland, while England and Wales recommended vaccination of front line HCWs only or those HCWs who have direct contact with patients. Policy recommendations, payment schemes and uptake of seasonal influenza vaccine in health care workers in EU/EEA Member States assessed for the 2009/2010 to 2014/2015 influenza seasons • No MS enforces mandatory vaccination of staff. Some health care settings in MSs required unvaccinated staff to wear a mask during the influenza season. • Payment schemes for vaccine/vaccination varied, with the employer, national or regional health services covering the cost of in 19 MS while 4 reported that at least some HCWs paid out of pocket. In the remaining seven countries a combination of several payment mechanisms exists (e.g. private insurance, out of pocket, employer or national insurance scheme). • Uptake of seasonal influenza vaccination in HCWs was reported from fourteen EU/EEA MS and ranged between 5-55% in 2014-15. Information was collected by the administrative method (n= 13) or the survey method (n=1). Uptake in HCWs was often but not always lower than uptake in older populations, with a median uptake of ~25% among HCWs (n=17) compared to ~40% in older populations (n=26). Figure 2. Seasonal influenza vaccination coverage rates among HCWs in EU/EEA MSs 2009-10 to 2014-15 influenza seasons No recommendation Recommended for all HCWs Recommended for some* HCWs * Health care workers in GPs practice/Outpatient health care settings Conclusions • Vaccine policy recommendations for HCWs to be vaccinated against influenza exist in almost all EU/EEA MSs • Payment schemes vary but are available in all EU/EEA MSs. • Among those EU/EEA MSs reporting uptake there is room for significant improvement in uptake of seasonal influenza vaccination in HCWs • There is a need for collection of uptake of seasonal influenza vaccination in HCWs in all EU/EEA MSs Affiliations: 1Health Protection Surveillance Centre, Dublin, Ireland , 2European Centre for Disease Prevention and Control, Stockholm, Sweden, 3Istituto Superiore di Sanità, Rome, Italy, 4Institut de Viellle Sanitaire, Saint-Maurice, France,5CINECA Consortium of Universities, Bologna, Italy, 6Statens Serum Institut, Copenhagen, Denmark, 7Robert Koch Institute, Berlin, Germany, 8National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland, 9Vaccine European New Integrated Collaboration Effort (VENICE) Project, 10The list of gatekeepers is available in the final report on VENICE website: http://venice.cineca.org Acknowledgements: We are grateful to all VENICE gatekeepers/contact points in each EU/EEA MS that contributed data presented on this poster, Figure 1. EU/EEA MSs recommending seasonal influenza vaccine for health care workers. *Some is defined as e.g. outpatient/inpatient/long term care facilities workers/ front line HCWs/ those HCWs who have direct contact with patient. 0 10 20 30 40 50 60 70 80 90 100 Vaccinationcoverage(%) 2009-10 2010-11 2011-12 2012-13 2013-14 2014-15

Editor's Notes

  1. Please export the PowerPoint document as a PDF (File – Save as – PDF) and upload the PDF into the system. Please use the font in the document or a similar one and do not use a font size smaller than 16.